Brooks Laboratories Ltd Performance
Day's High
₹138.65₹138.7552 Week's Low
52 Week's High
₹73.25₹185.7
| Returns % | |
| 1 Month Return | -2.67 % |
| 3 Month Return | + 17.35 % |
| 1 Year Return | + 12.2 % |
| Market Stats | |
| Previous Close | ₹141.48 |
| Open | ₹138.65 |
| Volume | 5,526.00 |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹371.34Cr |
Brooks Laboratories Ltd Key Statistics
| P/E Ratio | -18.3 |
| PEG Ratio | 11.48 |
| Market Cap | ₹371.34 Cr |
| P/B Ratio | 3.5 |
| EPS | -7.46 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 1.9 |
Brooks Laboratories Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹371.34 Cr | 92.11% | 0.55 | -₹20 Cr | ₹79 Cr | |
| NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
| NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
| NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
| NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Brooks Laboratories Ltd Mutual Fund Holdings
About Brooks Laboratories Ltd
Brooks Laboratories Ltd was established in January 2002 and it started operations and commercial production in May and June 2006 respectively. It obtained an ISO 9001:2008 Certificate in August 2007 and an Import License from Drugs Controller General of India in October 2006. On August 2011, they raised Rs. 63 crore through IPO and their shares officially listed on stock exchanges in September 2011.
Their current manufacturing facility at Baddi is 100% operational, with world class dedicated carbapenem facility in Vadodara Plant which commenced activity on 7 March 2017. Baddi facility was upgraded in June 2017 for 3 months, and production in injectable line resumed from September onwards. Finally, production commenced in August 2017 in the renovated building and was almost double than the previous line.
Share Price: ₹138.65 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹371.34Cr as of today
Revenue: ₹20.79Cr as on September 2024 (Q3 24)
Net Profit: ₹-3.96Cr as on September 2024 (Q3 24)
Listing date: 05 Sep, 2011
| Organisation | Brooks Laboratories Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Insights on Brooks Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 18.0 Cr → 20.99 Cr (in ₹), with an average increase of 14.2% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, BROOKS stock has moved up by 4.0%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.00% to 0.02% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 92.6%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 63.59% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 46.4%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 32.55% to 32.53% in Sep 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -2.41 Cr → -3.96 Cr (in ₹), with an average decrease of 64.3% per quarter
Brooks Laboratories Ltd Financials
Brooks Laboratories Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 63.59% | 0.00 | |
| Foreign Institutions | 0.02% | 0.00 | |
| Mutual Funds | 3.86% | 0.00 | |
| Retail Investors | 32.53% | ||
| Others | 0% | 0.00 |
Brooks Laboratories Ltd Key Indicators
Brooks Laboratories Ltd Valuation
Brooks Laboratories Ltd in the last 5 years
Lowest (-31.36x)
January 11, 2024
Today (-18.30x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (-5.43x)
May 25, 2023
Brooks Laboratories Ltd Earnings and Dividends
Brooks Laboratories Ltd Earnings Results
Brooks Laboratories Ltd’s net profit fell -141.46% since last year same period to ₹-3.96Cr in the Q2 2024-2025. On a quarterly growth basis, Brooks Laboratories Ltd has generated -64.32% fall in its net profits since last 3-months.
Read More about Earnings Results
Brooks Laboratories Ltd Technicals Summary
Bearish
Neutral
Bullish
Brooks Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Brooks Laboratories Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Brooks Laboratories Ltd shares.
Brooks Laboratories Ltd (BROOKS) share price today is ₹138.65
Brooks Laboratories Ltd is listed on NSE
Brooks Laboratories Ltd is listed on BSE
- Today’s highest price of Brooks Laboratories Ltd is ₹138.75.
- Today’s lowest price of Brooks Laboratories Ltd is ₹138.65.
PE Ratio of Brooks Laboratories Ltd is -18.3
PE ratio = Brooks Laboratories Ltd Market price per share / Brooks Laboratories Ltd Earnings per share
Today’s traded volume of Brooks Laboratories Ltd(BROOKS) is 5,526.00.
Today’s market capitalisation of Brooks Laboratories Ltd(BROOKS) is ₹371.34Cr.
| Brooks Laboratories Ltd(BROOKS | Price |
|---|---|
52 Week High | ₹185.7 |
52 Week Low | ₹73.25 |
Brooks Laboratories Ltd(BROOKS) share price is ₹138.65. It is down -25.34% from its 52 Week High price of ₹185.7
Brooks Laboratories Ltd(BROOKS) share price is ₹138.65. It is up 89.28% from its 52 Week Low price of ₹73.25
| Brooks Laboratories Ltd(BROOKS | Returns |
|---|---|
1 Day Returns | -2.83% |
1 Month Returns | -2.67% |
3 Month Returns | 17.35% |
1 Year Returns | 12.2% |